top of page
Published in
Visionary Voices
Development and Technical Characterization of the WHITESTONE Phytoionic Hydrogen Infuser: A Novel Framework for Stable Hydrogen-Rich Water in Wellness Applications
Visionary Voices, 2(5), 21-22, ISSN: 3082-4389, 2026.
Recommended Citation:
ER-ER, D. K. I. R. M., & RODERICK, I. N. R. (2026). Development and Technical Characterization of the WHITESTONE Phytoionic Hydrogen Infuser: A Novel Framework for Stable Hydrogen-Rich Water in Wellness Applications. In Visionary Voices (Vol. 2, Number 5, pp. 21–22). Lakbay-Diwa Publishing. https://doi.org/10.5281/zenodo.20346252
Author(s)
Er-Er, Datu Kresmedereh Inv. Ronie M., Roderick, Inv. Nicolas R.
Description
Molecular hydrogen (H2) is increasingly recognized in biomedical science as a unique, selective antioxidant. Unlike conventional antioxidants, H2 selectively neutralizes cytotoxic oxygen radicals—specifically the hydroxyl radical (.OH) and peroxynitrite—thereby mitigating oxidative stress without interfering with essential signaling reactive oxygen species (ROS). Despite its significant therapeutic potential, a primary technical challenge persists: the generation of high-concentration, stable hydrogen-rich water (HRW) that maintains bioavailable properties for practical human consumption. This study details the design, fabrication, and performance evaluation of the WHITESTONE Phytoionic Hydrogen Infuser, a portable system engineered to optimize H2 dissolution and electrochemical stability. Utilizing a developmental-experimental research design, the prototype bridges the gap between conventional electrolysis and mineral-based catalysis by integrating food-grade titanium-platinum electrodes with a specialized phytoionic infusion chamber containing plant-based mineral catalysts to enhance ionization efficiency. The electrochemical system was operated under strictly controlled conditions, utilizing a direct-current (DC) range of 1.5–3.5 V and 0.5–2.0 A. Analytical procedures focused on quantifying dissolved hydrogen concentration, oxidation-reduction potential (ORP), pH stability, and electrochemical durability. Results demonstrated that the WHITESTONE Infuser successfully achieved dissolved molecular hydrogen (H2) concentrations ranging from 1,200 ppb to 1,550 ppb, significantly exceeding the minimum therapeutic threshold of 500 ppb typically cited in clinical literature. Crucially, the system produced a highly reductive environment, with ORP values measured between -440 mV and -530 mV, confirming its high antioxidant potential. A key finding was that the integration of phytoionic catalysts enhanced the ionization efficiency and provided superior gas-liquid phase stability compared to standard electrolysis units. Furthermore, the device maintained a slightly alkaline pH balance of 7.5–8.5, which is considered optimal for physiological homeostasis and oral consumption. The system demonstrated consistent operational safety and portability, fulfilling the requirements for sustainable, household-level preventive health technology. The hydrogen output aligns with the Generally Recognized as Safe (GRAS) classification by the FDA, as excess H2 is physiologically inert and excreted via the lungs. This framework establishes a robust technical basis for mineral-enhanced hydrogen infusion. However, while technical efficacy is established, further longitudinal clinical trials and toxicological assessments are required to validate specific therapeutic outcomes and ensure international regulatory compliance for commercial deployment.
bottom of page